Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments.
Ori Biotech has raised $100.0M in total funding. The most recent round was Series B. The last funding was announced in January 2022.
Ori Biotech's investors include Octopus Ventures, Kindred Capital, Amadeus Capital Partners, Puhua Capital, Novalis LifeSciences.
Ori Biotech is headquartered in London, United Kingdom.
Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments.
Ori Biotech is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ori Biotech — Funding & Investors." VCBacked, January 18, 2022, https://www.vcbacked.co/company/ori-biotech. Accessed August 15, 2026.
VCBacked. (2022). Ori Biotech — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/ori-biotech
{{cite web |title=Ori Biotech — Funding & Investors |url=https://www.vcbacked.co/company/ori-biotech |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated